N-Allylnoroxymorphone en es it fr

N-Allylnoroxymorphone Brand names, N-Allylnoroxymorphone Analogs

N-Allylnoroxymorphone Brand Names Mixture

  • No information avaliable

N-Allylnoroxymorphone Chemical_Formula


N-Allylnoroxymorphone RX_link


N-Allylnoroxymorphone fda sheet

N-Allylnoroxymorphone msds (material safety sheet)

N-Allylnoroxymorphone MSDS

N-Allylnoroxymorphone Synthesis Reference

No information avaliable

N-Allylnoroxymorphone Molecular Weight

327.374 g/mol

N-Allylnoroxymorphone Melting Point

200 - 205 oC

N-Allylnoroxymorphone H2O Solubility


N-Allylnoroxymorphone State


N-Allylnoroxymorphone LogP


N-Allylnoroxymorphone Dosage Forms


N-Allylnoroxymorphone Indication

For the complete or partial reversal of narcotic depression, including respiratory depression, induced by opioids including natural and synthetic narcotics, propoxyphene, methadone and the narcotic-antagonist analgesics: nalbuphine, pentazocine and butorphanol.

N-Allylnoroxymorphone Pharmacology

Naloxone is an opiate antagonist and prevents or reverses the effects of opioids including respiratory depression, sedation and hypotension. Also, it can reverse the psychotomimetic and dysphoric effects of agonist-antagonists such as pentazocine. Naloxone is an essentially pure narcotic antagonist, i.e., it does not possess the "agonistic" or morphine-like properties characteristic of other narcotic antagonists; naloxone does not produce respiratory depression, psychotomimetic effects or pupillary constriction. In the absence of narcotics or agonistic effects of other narcotic antagonists, it exhibits essentially no pharmacologic activity.

N-Allylnoroxymorphone Absorption

Well absorbed following intramuscular injection.

N-Allylnoroxymorphone side effects and Toxicity

No information avaliable

N-Allylnoroxymorphone Patient Information

No information avaliable

N-Allylnoroxymorphone Organisms Affected

Humans and other mammals